BioCentury
ARTICLE | Clinical News

iCo-007: Phase I data

September 29, 2008 7:00 AM UTC

An open-label, dose-escalation, U.S. Phase I trial in 15 to 30 patients with diffuse diabetic macular edema (DME) had a third cohort of patients approved by the trial's Safety Evaluation Committee. No...